Navigation Links
OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance
Date:7/9/2009

tice staff so that they can spend more time caring for the patient. The professionals at Care Advantage are savvy in matching the needs of the patient to the appropriate funding opportunities. Care Advantage pharmacy services are available to all community-based oncology practices throughout the United States and in Puerto Rico.

Nearly two-thirds of the $15 million supplied to cancer patients through OncologyRx Care Advantage came from the Chronic Disease Fund, which raises funds with the sole intent of assisting people with chronic diseases so that they can afford to remain on their recommended treatment schedules.

"It makes us proud to know we have made a difference in the lives of those patients who need us," says Mike Banigan, founder and president of Chronic Disease Fund. "Partnering with a resource like OncologyRx Care Advantage not only allows us to help patients get the medications they so desperately need, but also the focused patient care they deserve."

Duane Reeder, a 75 year old cancer patient from Tucson, Ariz., was 60 years old when he was first diagnosed with kidney cancer in March of 1994. In 2003, doctors at Arizona Oncology, a community-based oncology practice affiliated with US Oncology, found that his renal cell carcinoma had metastasized to his lungs; by 2006, he was in the advanced stages of his disease.

Reeder's physicians began treating him with Nexavar, an oral multiple kinase inhibitor that has been shown to significantly slow the spread of advanced kidney cancer in a majority of patients. By filling his prescription through OncologyRx Care Advantage, Reeder was eligible to receive support from CARxES(SM), the Chemotherapy Adherence & Prescription Education Su
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Elsevier Launches Ten New eBook Specialty Collections on MD Consult
2. Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices
3. Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program
4. B. Braun Technology Wins Novation Specialty Infusion Pumps Contract Award
5. Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations
6. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
7. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
8. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
11. A Perfect Storm Threatens Patient Access to Specialty Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider of ... one of India’s top five pharmaceutical companies, has received ... for high throughput solid form screening. , Lupin, ... range of quality, affordable generic and branded formulations and ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... 7 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... Corporate Development of BioMarin, will present a company update at ... 14, 2009 at 10:40 a.m. CT. Interested parties may ... the investor section of the BioMarin website, www.BMRN.com ...
... deCODE genetics, Inc.,(Nasdaq: DCGN ) today announced that it ... release to be issued on Monday, May 11, after,the close ... a live webcast of,its conference call to discuss these results ... Daylight Time/ 12pm GMT/1pm British Summer,Time. , ...
... (NYSE: CVD ) announced that it has ... McCartney currently serves as chairman of the board of ... and supply chain solutions. He was formerly president ... multibillion dollar provider of information access technologies. He was ...
Cached Biology Technology:BioMarin to Present at the Baird Growth Stock Conference 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results 2Covance Elects John McCartney to Company's Board of Directors 2
(Date:4/24/2014)... generation of military veterans returning home from Iraq and ... concern in American medical institutions and the culture at-large. ... personnel deployed to Iraq and Afghanistan suffer from PTSD. ... of Medicine is shedding light on how PTSD is ... , The rise in PTSD has implications beyond the ...
(Date:4/24/2014)... liquid can bend light, acting as a lens. Now, ... new process to create inexpensive high quality lenses that ... Because they,re so inexpensive, the lenses can be used ... diseases in the field, scientific research in the lab ... , "What I,m really excited about is that ...
(Date:4/23/2014)... satellite data shows Africa,s Congo rainforest, the second-largest tropical ... in greenness over the past decade. , The study, ... University of New York, shows between 2000 and 2012 ... and intensified. The research, published Wednesday in Nature ... to explore the effects of long-term drought on the ...
Breaking Biology News(10 mins):New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3Bake your own droplet lens 2Bake your own droplet lens 3NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3
... PHOENIX, Ariz. Feb. 2, 2009 A drug used ... improve learning and memory and reduce the risk of Alzheimer,s ... at the Translational Genomics Research Institute (TGen) and Arizona State ... years to help protect the brain in stroke patients by ...
... treatment, but it,s not always effective. Successful chemotherapy depends ... the bloodstream through the leaky blood vessels that often ... of individuals from unnecessary toxicity and the often difficult ... published in the February issue of the journal ...
... lab in India that stops tuberculosis in its tracks. In ... crucial metabolic pathways at the same time, weakening and ultimately ... will not work in humans. Not willing to set aside ... doors of pharmaceutical companies to see if he can get ...
Cached Biology News:TGen and ASU researchers find drug that could reduce risk of Alzheimer's 2TGen and ASU researchers find drug that could reduce risk of Alzheimer's 3New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 2New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 3In India: A search for more effective tuberculosis drugs 2In India: A search for more effective tuberculosis drugs 3
... Source: E. coli strain containing an ... M-MLV Reverse Transcriptase catalyzes the polymerization ... RNA:DNA hybrids(1). Full-length copies of large mRNAs, ... Transcriptase has a much lower RNase H ...
...
RNase-Free DNase 50 l...
... T7 RNA polymerase is a DNA-dependent ... T7 phage promoters. It efficiently synthesizes ... that is down stream from a T7 ... hybridization probes, templates for in vitro translation, ...
Biology Products: